155 related articles for article (PubMed ID: 3305390)
1. Recombinant interferon alfa-2a, an active agent in advanced cutaneous T-cell lymphomas.
Bunn PA; Ihde DC; Foon KA
Int J Cancer Suppl; 1987; 1():9-13. PubMed ID: 3305390
[TBL] [Abstract][Full Text] [Related]
2. The role of recombinant interferon alfa-2a in the therapy of cutaneous T-cell lymphomas.
Bunn PA; Ihde DC; Foon KA
Cancer; 1986 Apr; 57(8 Suppl):1689-95. PubMed ID: 3485012
[TBL] [Abstract][Full Text] [Related]
3. Recombinant leukocyte A interferon: an active agent in advanced cutaneous T-cell lymphomas.
Bunn PA; Foon KA; Ihde DC; Longo DL; Eddy J; Winkler CF; Veach SR; Zeffren J; Sherwin S; Oldham R
Ann Intern Med; 1984 Oct; 101(4):484-7. PubMed ID: 6332565
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic options in advanced cutaneous T cell lymphomas: a role for interferon alfa-2a (Roferon-A).
Bunn PA; Foon KA
Semin Oncol; 1985 Dec; 12(4 Suppl 5):18-24. PubMed ID: 3878594
[TBL] [Abstract][Full Text] [Related]
5. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970
[TBL] [Abstract][Full Text] [Related]
6. Combined modality therapy for cutaneous T-cell lymphoma.
Duvic M; Lemak NA; Redman JR; Eifel PJ; Tucker SL; Cabanillas FF; Kurzrock R
J Am Acad Dermatol; 1996 Jun; 34(6):1022-9. PubMed ID: 8647968
[TBL] [Abstract][Full Text] [Related]
7. Alpha-interferon treatment of cutaneous T cell lymphoma and chronic lymphocytic leukemia.
Foon KA; Bunn PA
Semin Oncol; 1986 Dec; 13(4 Suppl 5):35-9. PubMed ID: 3541217
[TBL] [Abstract][Full Text] [Related]
8. Phase II trial of fludarabine phosphate and interferon alfa-2a in advanced mycosis fungoides/Sézary syndrome.
Foss FM; Ihde DC; Linnoila IR; Fischmann AB; Schechter GP; Cotelingam JD; Steinberg SM; Ghosh BC; Stocker JL; Bastian A
J Clin Oncol; 1994 Oct; 12(10):2051-9. PubMed ID: 7931473
[TBL] [Abstract][Full Text] [Related]
9. Interferon alfa-2a in the treatment of cutaneous T cell lymphoma.
Olsen EA; Rosen ST; Vollmer RT; Variakojis D; Roenigk HH; Diab N; Zeffren J
J Am Acad Dermatol; 1989 Mar; 20(3):395-407. PubMed ID: 2783939
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and tolerability of currently available therapies for the mycosis fungoides and Sezary syndrome variants of cutaneous T-cell lymphoma.
Whittaker SJ; Foss FM
Cancer Treat Rev; 2007 Apr; 33(2):146-60. PubMed ID: 17275192
[TBL] [Abstract][Full Text] [Related]
11. Phase II study of recombinant human interferon gamma for treatment of cutaneous T-cell lymphoma.
Kaplan EH; Rosen ST; Norris DB; Roenigk HH; Saks SR; Bunn PA
J Natl Cancer Inst; 1990 Feb; 82(3):208-12. PubMed ID: 2104937
[TBL] [Abstract][Full Text] [Related]
12. Mycosis fungoides and Sézary syndrome: focus on the current treatment scenario.
Sanches JA; Cury-Martins J; Abreu RM; Miyashiro D; Pereira J
An Bras Dermatol; 2021; 96(4):458-471. PubMed ID: 34053802
[TBL] [Abstract][Full Text] [Related]
13. High-dose recombinant interleukin-2 in advanced cutaneous T-cell lymphoma.
Marolleau JP; Baccard M; Flageul B; Rybojad M; Laroche L; Vérola O; Brandely M; Morel P; Gisselbrecht C
Arch Dermatol; 1995 May; 131(5):574-9. PubMed ID: 7741545
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of interferon alfa-2a combined with phototherapy for mycosis fungoides and the Sézary syndrome.
Kuzel TM; Roenigk HH; Samuelson E; Herrmann JJ; Hurria A; Rademaker AW; Rosen ST
J Clin Oncol; 1995 Jan; 13(1):257-63. PubMed ID: 7799028
[TBL] [Abstract][Full Text] [Related]
15. Alpha interferon treatment of low-grade B-cell non-Hodgkin's lymphomas, cutaneous T-cell lymphomas, and chronic lymphocytic leukemia.
Foon KA; Roth MS; Bunn PA
Semin Oncol; 1986 Sep; 13(3 Suppl 2):35-42. PubMed ID: 3532334
[TBL] [Abstract][Full Text] [Related]
16. Phase II trial of intermittent high-dose recombinant interferon alfa-2a in mycosis fungoides and the Sézary syndrome.
Kohn EC; Steis RG; Sausville EA; Veach SR; Stocker JL; Phelps R; Franco S; Longo DL; Bunn PA; Ihde DC
J Clin Oncol; 1990 Jan; 8(1):155-60. PubMed ID: 2295906
[TBL] [Abstract][Full Text] [Related]
17. [Alpha interferon in the therapy of cutaneous T cell lymphomas].
Lang MH; Altmeyer P; Lodemann E; Holzmann H
Z Hautkr; 1986 May; 61(9):599-608. PubMed ID: 3487184
[TBL] [Abstract][Full Text] [Related]
18. Systemic therapy of cutaneous T-cell lymphomas (mycosis fungoides and the Sézary syndrome).
Bunn PA; Hoffman SJ; Norris D; Golitz LE; Aeling JL
Ann Intern Med; 1994 Oct; 121(8):592-602. PubMed ID: 8085692
[TBL] [Abstract][Full Text] [Related]
19. Is interferon alpha in cutaneous T-cell lymphoma a treatment of choice?
Papa G; Tura S; Mandelli F; Vegna ML; Defazio D; Mazza P; Zinzani PL; Simoni R; DePita O; Ferranti G
Br J Haematol; 1991 Oct; 79 Suppl 1():48-51. PubMed ID: 1931709
[TBL] [Abstract][Full Text] [Related]
20. Mycosis fungoides and the Sézary syndrome: pathology, staging, and treatment.
Hoppe RT; Wood GS; Abel EA
Curr Probl Cancer; 1990; 14(6):293-371. PubMed ID: 2245651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
